Jaguar Health Stockholders Approve All Proposals at 2026 Meeting

Jaguar Health, Inc. (NASDAQ:JAGX) announced that all proposals were approved by stockholders at the adjourned Annual Meeting held on June 8, 2026. The initial meeting occurred on May 22, 2026. Details of these proposals are in the company's proxy statement filed with the SEC on April 30, 2026. Stakeholders can access this document via the SEC’s website or Jaguar’s corporate site.

Jaguar's founder, Lisa Conte, will present at the Emerging Growth Conference on June 10, 2026. The event will feature a virtual session from 12:35 to 1:05 PM Eastern. Interested parties can register online and access the presentation on EmergingGrowth.com and YouTube following the event.